Method of treating prostatic adenocarcinoma
US5300294A · kind A · utility
27Cited by
9References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 1990 |
| Grant date | Apr 5, 1994 |
| Priority date | — |
| Expiry date | Jun 27, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Invented is a Method of Treating Prostatic Adenocarcinoma by employing a steroid 5-.alpha.-reductase inhibiting compound or a combination of steroid 5-.alpha.-reductase inhibiting compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.